Cardiovascular disease has always been one of the most concerning ailments of all times considering mortality. On one end due to the emergence of pharmaceutical technology, there is a reduction in mortality, on the other hand owing to a sedentary lifestyle the incidence of this disease is increasing. Hence leading to up slopping trend in cardiovascular prevalence. Acute coronary syndrome is one of the most deadly and acute presentations of cardiology requiring immediate intervention to dampen the frequency of complications. One of the fundamental goals in the treatment of ACS is to lower the heart rate so that load on myocardial tissue can be reduced. In order to do so, we already have multiple options like beta-blockers, calcium channel blockers, and new generation ivabradine (not affecting blood pressure unlike others).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Heart Rate
Timeframe: upto 72 hours
Duration of Hospital stay
Timeframe: upto 14 days
Mortality
Timeframe: upto 14 days
recurrent symptomatic ischemia
Timeframe: 72 hours
erythrocyte sedimentation rate (ESR)
Timeframe: upto 72 hours
C-reactive protein (CRP)
Timeframe: upto 72 hours